Citadel Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Citadel Advisors's BTAL Position: Q2 2026 in Review
Citadel Advisors opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 114,285 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #7606 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BTAL as recently as Q3 2025.
Citadel Advisors first reported a position in BTAL in Q2 2016 and has held it in 14 quarters since. The position peaked at $8.28M in Q3 2020. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Citadel Advisors held 114,285 shares of AGF US Market Neutral Anti-Beta Fund worth $1.27M as of Q2 2026.
- AGF US Market Neutral Anti-Beta Fund was a new Citadel Advisors position in Q2 2026.
- AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7606 holding.
- Citadel Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2016 and has held it in 14 quarters since.
- Citadel Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $8.28M in Q3 2020.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.